<DOC>
	<DOCNO>NCT00073554</DOCNO>
	<brief_summary>This trial patient acute occlusion one arteries supply blood leg . The trial design determine safety activity novel clot dissolving ( thrombolytic ) drug ( alfimeprase ) .</brief_summary>
	<brief_title>Alfimeprase Thrombolysis Acute Peripheral Arterial Occlusion</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<criteria>Patients acute peripheral arterial occlusion lower limb ( onset symptom within 14 day ) Rutherford Class I IIa ( minimal sensory loss , muscle weakness , audible venous flow ) Age 18 Able consent Able follow</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>